Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05775614
Other study ID # UROBIQ
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date May 1, 2022
Est. completion date January 1, 2026

Study information

Verified date April 2024
Source Odense University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the current study is to investigate whether catheter flushing with Uro-Tainer® with citric acid and Uro-Tainer® Polihexanide can: Reduce catheter changes due to incrustation and blockage. In addition, a list of secondary aims inclusive of cost-effectiveness analysis in collaboration with the Centre for Innovative Medical Technology (CIMT) at OUH.


Description:

The purpose of the current study is to investigate whether catheter flushing with Uro-Tainer® with citric acid and Uro-Tainer® Polihexanide can: Reduce catheter changes due to incrustation and blockage. In addition, a list of secondary aims inclusive of cost-effectiveness analysis in collaboration with the Centre for Innovative Medical Technology (CIMT) at OUH. This randomised study will be performed in two phases: a pilot and the main study. There is a need for a randomised study to justify if Uro-Tainer® flushing will have an advantage instead of the cheaper and normally used Saline flushing. Standard therapies vary depending on the blockage type and severity. Saline Solution can be used daily for a shorter period and 1-2 times a week for long-time catheter maintenance. Pilot study: Uro-Tainer® Polihexanide twice a week for 12 weeks and compared to saline flushing in the same regime. Main study: - Uro-Tainer® Polihexanide two weekly rinses compared to two weekly rinses with saline for 6 months. - Uro-Tainer® with citric acid: Two weekly rinses compared to two weekly rinses with saline for 6 months. Clinical benefits: - Less catheter blockage -> less need for catheter replacement outside the regular schedule -> Fewer infections and better QoL - It is expected that cost-effectiveness analysis will show a better economic outcome for the society - No unknown adverse effects are expected - The risk of participation in this study is very small compared to the expected effect of fewer catheter replacements, fewer infections and better QoL which justifies the selection of clinical endpoints.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 170
Est. completion date January 1, 2026
Est. primary completion date January 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Citizen not previously flushed - A permanent catheter (suprapubic and urethral) - Male and female > 18 years of age - Acute or previous catheter stop because of blocking or incrustations. - The pilot project does not include clogging due to incrustations - Voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the Ethics Committee (EC) before all evaluations. Citizen previously flushed with NaCl or UroTainer® - A permanent catheter (suprapubic and urethral) - Male and female > 18 years of age - Willingness to take a rinse break for a minimum of 4 weeks. In the event of 2 catheter stops during the flushing break, assessed on the basis of an urgent need for catheter flushing with NaCl or catheter change, the citizen can be included. - The pilot project does not include clogging due to incrustations - If there is no catheter stop during the rinsing break, the citizen will continue without rinsing until a possible catheter stop. - Voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the Ethics Committee (EC) before all evaluations. Exclusion Criteria: - Urothelial cancer - Bladder and kidney stones requiring treatment - Age < 18 years of age - Pregnant and / or breastfeeding women - Not able to understand Danish - Dementia, where relatives can / will not give consent - Simultaneous participation in another interventional clinical trial (drugs or medical devices studies)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
UroTainer®
Clinical effect of preventive treatment - catheter flushing with UroTainer®
Saline
Clinical effect of preventive treatment - catheter flushing with saline solution

Locations

Country Name City State
Denmark Odense University Hospital Odense

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of catheter changes during the treatment and follow-up period. Number of catheter changes 1 year
Secondary UTI events The number of prescriptions 1 year
Secondary Urine culture Urine culture performed if UTI is suspected 1 year
Secondary Odour Odour nuisance is to be assessed on a 5-point scale. A high score is a worse outcome.
No odour
Discreet odour nuisance after catheter care
Odour that is noticed once in a while. Noticed by the participant and relatives
Odour that is present all the time around the participant
Solid odour that is felt in all rooms. "It hangs" on the participant
1 year
Secondary Quality of life by SF-36 SF-36 (Health Survey Short Form 36)
The SF-36 consists of 36 items - that are grouped into 8 subscales or domains:
Physical functioning (10 items); Role limitations due to physical health (4 items); Role limitations due to emotional problems (4 items); Energy/fatigue; Emotional well-being; Social functioning (2 items); Pain (2 items); General health. Aggregate scores for each domain range from 0 to 100, compiled as a percentage - where the higher the score, the more favourable the health state.
1 year
Secondary Quality of life by ICIQ-LTCqol Living with a long term catheter (ICIQ-LTCqol 12/12 ) The questionnaire consists of three scales yielding two summary measures catheter function and concern score, lifestyle impact and unscored items. Possible scores range from 1 to 530, with lower scores representing better catheter function, concern score and life impact. 1 year
Secondary Cost effectiveness analyses 1 Costs of used catheters in DDK pr participant 1 year
Secondary Cost effectiveness analyses 2 Costs of used solutions for the maintenance of indwelling urethral and suprapubic catheters in DKK pr participant 1 year
Secondary Cost effectiveness analyses 3 Costs of used time of the health care professionals used for catheter maintenance and control in primary care in DKK pr participant 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04548713 - CLiCK in the Critical Care Unit N/A
Recruiting NCT05931887 - Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention N/A
Completed NCT04772209 - Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters N/A
Recruiting NCT05168943 - Nylon Versus Polyurethane Epidural Catheters In Patients Undergoing Major Orthopedic Surgery N/A
Completed NCT04205695 - Comparison of Catheters Orifice Configuration For Continuous Infraclavicular Analgesia N/A
Completed NCT04202250 - The Efficacy of Continuous Femoral Nerve Catheter Orifice Configuration for Postoperative Analgesia in Knee Arthroplasty N/A
Completed NCT04212325 - Efficacy of Continuous Sciatic Nerve Block in Diabetic Foot Patients N/A
Terminated NCT03976557 - BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden N/A